Collaborative Research: RECODE: Microfluidic and genetic technologies to direct and select retinal cell types from human induced pluripotent stem cell-derived retinal organoids

合作研究：RECODE：微流体和遗传技术从人类诱导多能干细胞衍生的视网膜类器官中指导和选择视网膜细胞类型

• 批准号: 2225488
• 负责人: Budd Tucker
• 金额: $ 54.17万
• 依托单位: University of Iowa
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-10-01 至 2026-09-30
• 项目状态: 未结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=2225488&HistoricalAwards=false
• 关键词: Collaborative; Research; RECODE; Microfluidic; genetic

The differentiation of cells is the result of a complicated set of processes. Most stem cell differentiation methods result in a mixture of desired and undesired cell types. Better understanding of key molecular control points of differentiation could decrease the generation of undesirable cells. That in turn could increase the effectiveness of cell-based therapies. Genetic and mechanical techniques will be employed to better understand the differentiation pathway resulting in retinal cells. The hope is that this will lead to new treatments for degenerative eye diseases. Biomanufacturing workforce development will also be supported in several ways. Graduate students will be trained in stem cell biology and bioengineering, undergraduate students will be provided research opportunities, and outreach to industry will be accomplished through the Center for Cell Manufacturing Technologies.Controlling human induced pluripotent stem cell (hiPSC) differentiation is a challenge. Cell molecular pathways are programmed to react to external cues. Most protocols depend to a great degree on spontaneous cell fate commitment. This often results in a heterogeneous mixture of tissue specific cell types, many of which are not needed, or detrimental, for regenerative cell replacement strategies. Applying microfluidic cell separation and geno-mechanical techniques will be evaluated for their ability to reliably direct differentiation of hiPSCs to retinal cells. The first objective is to develop genome-wide methods that use both cell differentiation and biomechanical properties as screens to target desired endpoints during retinal cell differentiation. This objective could uncover new target pathways that can be exploited during culture to regulate retinogenesis. The second objective is to use systems biology to identify master regulators of retinal cell differentiation These regulators will be validated by observing the effects of modulation of these pathways on differentiated retinal subtypes. A third objective is to use cell separation approaches coupled with novel markers to enhance the production of the proper proportion of rods to cones.This RECODE project is funded by the Engineering Biology and Health Cluster in the Division of Chemical, Bioengineering, Environmental, and Transport Systems.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

细胞的分化是一系列复杂过程的结果。大多数干细胞分化方法导致期望的和不期望的细胞类型的混合物。更好地理解分化的关键分子控制点可以减少不良细胞的产生。这反过来又可以提高基于细胞的疗法的有效性。遗传和机械技术将被用来更好地了解导致视网膜细胞的分化途径。希望这将导致新的治疗退行性眼病。生物制造业劳动力的发展也将以多种方式得到支持。研究生将接受干细胞生物学和生物工程方面的培训，本科生将获得研究机会，并通过细胞制造技术中心与工业界进行联系。控制人类诱导多能干细胞（hiPSC）分化是一项挑战。细胞分子通路被编程为对外部线索做出反应。大多数协议在很大程度上依赖于自发的细胞命运承诺。这通常导致组织特异性细胞类型的异质混合物，其中许多对于再生细胞替代策略是不需要的或有害的。应用微流体细胞分离和基因机械技术将评估其可靠地指导hiPSC分化为视网膜细胞的能力。第一个目标是开发全基因组方法，该方法使用细胞分化和生物力学特性作为筛选，以在视网膜细胞分化期间靶向所需的终点。这一目标可能会发现新的目标途径，可以利用在文化调节视网膜发生。第二个目标是使用系统生物学来鉴定视网膜细胞分化的主要调节剂。这些调节剂将通过观察这些通路对分化的视网膜亚型的调节作用来验证。第三个目标是使用细胞分离方法结合新的标记物来提高视杆细胞与视锥细胞的适当比例的产生。该RECODE项目由化学，生物工程，环境，该奖项反映了NSF的法定使命，并通过使用基金会的智力价值进行评估，更广泛的影响审查标准。